1. Assassi S, Radstake TRDJ, Mayes MD, Martin J. Genetics of scleroderma: implications for personalized medicine? BMC Med. BioMed Central Ltd; 2013;11(1):9.
2. Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Annu Rev Pathol. 2011;6(1):509–37.
3. Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, et al. Molecular subsets in the gene expression signatures of scleroderma skin. Butler G, editor. PLoS ONE. Public Library of Science; 2008;3(7):e2696.
4. Pendergrass SA, Lemaire R, Francis IP, Mahoney JM, Lafyatis R, Whitfield ML. Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies. J Invest Dermatol. Nature Publishing Group; 2012;132(5):1363–73.
5. Hinchcliff M, Huang C-C, Wood TA, Mahoney JM, Martyanov V, Bhattacharyya S, et al. Molecular Signatures in Skin Associated with ClinicalImprovement during Mycophenolate Treatment inSystemic Sclerosis. J Invest Dermatol. Nature Publishing Group; 2013;133(8):1979–89.